Menu Close

Stefan Schillberg

Executive Director, Fraunhofer IME

Stefan Schillberg mainly investigates Recombinant DNA, Antibody, Biotechnology, Molecular biology and Biochemistry. The various areas that Stefan Schillberg examines in his Recombinant DNA study include Proteases, Plant cell and Transgene. His Antibody research includes elements of Genetically modified crops, Microbiology and Virology.

His studies deal with areas such as Downstream processing and Suspension culture as well as Biotechnology. His Molecular biology study also includes fields such as

Nicotiana tabacum and related Cell culture,
Protein A most often made with reference to Affinity chromatography. When carried out as part of a general Biochemistry research project, his work on Enzyme, Ornithine decarboxylase, Nucleic acid and Putrescine is frequently linked to work in Glycolate dehydrogenase, therefore connecting diverse disciplines of study.
He most often published in these fields:
Recombinant DNA (27.23%)
Antibody (26.29%)
Biotechnology (24.41%)


  • –present
    Head of the Division Molecular Biotechnology, Fraunhofer ISI